Surgery Partners is trading 5% up at $14.40 as investors continue assessing its September 17 completion of the Idaho Falls facilities sale to Intermountain Health. - The transaction delivered $797 million in gross proceeds and $587 million in net cash proceeds, primarily for debt repayment. - Leverage is expected to improve, and 2026 guidance was updated after removing the facilities’ remaining contribution. - No major macro catalyst or fresh company announcement was identified for September 22, 2026.